Islandsbanki hf.
Íslandsbanki hf. has today issued the following bond under its Global Medium Term Notes (GMTN) Programme with the following terms:
Issuer: Íslandsbanki hf.
Issue Size: NOK 150,000,000
Value date: 26 March 2021
Maturity Date: 26 March 2024
Listing: Irish Stock Exchange
ISIN: TBC
Dealer: SEB
Issuer: Íslandsbanki hf.
Issue Size: NOK 750,000,000
Value date: 26 March 2021
Maturity Date: 26 March 2025
Listing: Irish Stock Exchange
ISIN: TBC
Dealers: Nordea, Swedbank
Issuer: Íslandsbanki hf.
Issue Size: SEK 250,000,000
Value date: 26 March 2021
Maturity Date: 26 March 2024
Listing: Irish Stock Exchange
ISIN: TBC
Dealers: Danske Bank
Issuer: Íslandsbanki hf.
Issue Size: SEK 450,000,000
Value date: 26 March 2021
Maturity Date: 26 March 2025
Listing: Irish Stock Exchange
ISIN: TBC
Dealers: SEB, Swedbank
Information on Íslandsbanki’s USD 2,500,000,000 GMTN and its supplements are available here.
For further information: ir@islandsbanki.is
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
FLSmidth A/S9.7.2025 08:41:33 CEST | Press release
Correction to Company Announcement no. 15-2025: Transactions under share buy-back programme
Syensqo SA9.7.2025 08:30:00 CEST | Press release
Syensqo - Participation notification by BlackRock Inc.
Sparekassen Sjælland-Fyn A/S9.7.2025 08:13:26 CEST | Pressemeddelelse
SJF Bank opjusterer forventningerne til resultatet for 2025
Ekopak N.V.9.7.2025 08:10:24 CEST | Press release
Ekopak appoints Jean-Baptiste De Cuyper as new CEO
Purespring Therapeutics9.7.2025 08:00:00 CEST | Press release
Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom